Data gathered: June 30
AI Stock Analysis - Atricure (ATRC)
Analysis generated May 20, 2025. Powered by Chat GPT.
Atricure, Inc. is a leading provider of innovative surgical solutions that enable the treatment of complex cardiac conditions. The company specializes in the development, manufacture, and sale of surgical devices designed to create precision lesions for the treatment of cardiac arrhythmias. With a strong focus on innovation and patient outcomes, Atricure is dedicated to advancing the field of cardiac surgery and improving the quality of life for patients.
Stock Alerts - Atricure (ATRC)
 |
Atricure | June 9 Gilbert Cisneros (member of U.S. congress) is buying shares |
|
Atricure | June 9 Gilbert Cisneros (member of U.S. congress) is buying shares |
|
Atricure | May 31 Insider Alert: Doraiswamy Vinayak is selling shares |
|
Atricure | May 18 Business Outlook among employees is down by 6.3% over the last month. |
Download our app to get future alerts delivered in real-time.
Alternative Data for Atricure
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 63 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 14,000 | Sign up | Sign up | Sign up |
| Employee Rating | 94 | Sign up | Sign up | Sign up |
| Google Trends | 37 | Sign up | Sign up | Sign up |
| Patents | 150 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 35 | Sign up | Sign up | Sign up |
| Facebook Followers | 1,307 | Sign up | Sign up | Sign up |
| Instagram Followers | 873 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 382 | Sign up | Sign up | Sign up |
| Twitter Followers | 2,652 | Sign up | Sign up | Sign up |
| Twitter Mentions | 102 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 1,140 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 88 | Sign up | Sign up | Sign up |
| Linkedin Employees | 1,285 | Sign up | Sign up | Sign up |
About Atricure
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally.
| Price | $32.77 |
| Target Price | Sign up |
| Volume | 295,770 |
| Market Cap | $1.6B |
| Year Range | $27.93 - $42.4 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Medical & Dental Instruments |
In the news
AtriCure, Inc.(NasdaqGM: ATRC) dropped from Russell 2500 Value IndexJune 29 - Finnhub |
|
AtriCure, Inc.(NasdaqGM: ATRC) dropped from Russell Small Cap Comp Value IndexJune 29 - Finnhub |
|
AtriCure, Inc.(NasdaqGM: ATRC) dropped from Russell 2000 Value IndexJune 29 - Finnhub |
|
 |
GAMMA Investing LLC Raises Position in AtriCure, Inc. (NASDAQ:ATRC)June 24 - ETF Daily News |
|
Harbor Capital Advisors Inc. Invests $916,000 in AtriCure, Inc. (NASDAQ:ATRC)June 14 - ETF Daily News |
|
AtriCure, Inc. (NASDAQ:ATRC) Receives Average Rating of “Buy” from AnalystsJune 7 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 124M | 31M | 93M | -6.7M | -6M | -0.140 |
| Q4 '24 | 124M | 32M | 93M | -16M | -9M | -0.080 |
| Q3 '24 | 116M | 29M | 87M | -7.9M | -940,000 | -0.170 |
| Q2 '24 | 116M | 30M | 86M | -8M | -1.6M | -0.170 |
| Q1 '24 | 109M | 28M | 81M | -13M | -7M | -0.280 |
Insider Transactions View All
| Doraiswamy Vinayak filed to sell 73,550 shares at $33.4. May 30 '25 |
| Prange Karen filed to sell 17,828 shares at $38.1. March 7 '25 |
| Yuen Maggie filed to sell 8,970 shares at $24.1. August 19 '24 |
| Privitera Salvatore filed to buy 103,290 shares at $22.3. May 31 '24 |
| Noznesky Justin J filed to sell 71,284 shares at $24.1. May 3 '24 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Gilbert Cisneros |
Jun 9, 25 | Buy | $1K - $15K |
| Josh Gottheimer |
Aug 15, 24 | Buy | $1K - $15K |
| Josh Gottheimer |
Jul 9, 24 | Sell | $1K - $15K |
Read more about Atricure (ATRC) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Atricure?
The Market Cap of Atricure is $1.6B.
What is the current stock price of Atricure?
Currently, the price of one share of Atricure stock is $32.77.
How can I analyze the ATRC stock price chart for investment decisions?
The ATRC stock price chart above provides a comprehensive visual representation of Atricure's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Atricure shares. Our platform offers an up-to-date ATRC stock price chart, along with technical data analysis and alternative data insights.
Does ATRC offer dividends to its shareholders?
As of our latest update, Atricure (ATRC) does not offer dividends to its shareholders. Investors interested in Atricure should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Atricure?
Some of the similar stocks of Atricure are Align Technology, Dentsply, LeMaitre Vascular, iRhythm Technologies, and NovoCure.
.